ZIM Integrated gains on report Israeli minister may change his position on a sale
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
IonQ has "multiple ways to win" but investors are paying for growth that is not yet realized.
IonQ has "multiple ways to win" but investors are paying for growth that is not yet realized.
Palo Alto Networks led the declines on the Tel Aviv 35 Index while Tower bucked the market.
Moderna has the clinical lead, while BioNTech has the deeper war chest. See which cancer stock offers the stronger long-term setup as mRNA oncology enters a new phase.